CN115768433A - 含有司培前列素的医药制剂 - Google Patents
含有司培前列素的医药制剂 Download PDFInfo
- Publication number
- CN115768433A CN115768433A CN202180044806.9A CN202180044806A CN115768433A CN 115768433 A CN115768433 A CN 115768433A CN 202180044806 A CN202180044806 A CN 202180044806A CN 115768433 A CN115768433 A CN 115768433A
- Authority
- CN
- China
- Prior art keywords
- glaucoma
- ocular hypertension
- pharmaceutical preparation
- treatment
- spoprost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020136796 | 2020-08-13 | ||
| JP2020-136796 | 2020-08-13 | ||
| PCT/JP2021/029701 WO2022034909A1 (ja) | 2020-08-13 | 2021-08-12 | セペタプロストを含有する医薬製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115768433A true CN115768433A (zh) | 2023-03-07 |
Family
ID=80248014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180044806.9A Pending CN115768433A (zh) | 2020-08-13 | 2021-08-12 | 含有司培前列素的医药制剂 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230285411A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4197540A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2022034909A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230051199A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115768433A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202220666A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022034909A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202404569A (zh) | 2022-04-22 | 2024-02-01 | 日商參天製藥股份有限公司 | 含有賽佩普斯特(Sepetaprost)之眼科用組合物 |
| TW202517277A (zh) * | 2023-10-10 | 2025-05-01 | 日商參天製藥股份有限公司 | 含有賽佩普斯特(Sepetaprost)之點眼液 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102498105A (zh) * | 2009-07-28 | 2012-06-13 | 小野药品工业株式会社 | 双环化合物及其医疗用途 |
| CN111526876A (zh) * | 2017-12-28 | 2020-08-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011013651A (ja) | 2009-07-03 | 2011-01-20 | Mitsumasa Maeda | フレキシブルディスプレイのれん |
| WO2019124489A1 (ja) * | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | セペタプロストとep2アゴニストとの組み合わせ医薬 |
| EP3730138B1 (en) * | 2017-12-21 | 2024-02-14 | Santen Pharmaceutical Co., Ltd. | Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension |
| JP2022508715A (ja) * | 2018-10-15 | 2022-01-19 | オキュフィア・ファーマ・インコーポレイテッド | 緑内障および関連状態の処置のための方法および組成物 |
-
2021
- 2021-08-12 JP JP2022542874A patent/JPWO2022034909A1/ja active Pending
- 2021-08-12 EP EP21855988.8A patent/EP4197540A4/en active Pending
- 2021-08-12 US US18/040,894 patent/US20230285411A1/en active Pending
- 2021-08-12 TW TW110129745A patent/TW202220666A/zh unknown
- 2021-08-12 KR KR1020237006743A patent/KR20230051199A/ko active Pending
- 2021-08-12 WO PCT/JP2021/029701 patent/WO2022034909A1/ja not_active Ceased
- 2021-08-12 CN CN202180044806.9A patent/CN115768433A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102498105A (zh) * | 2009-07-28 | 2012-06-13 | 小野药品工业株式会社 | 双环化合物及其医疗用途 |
| CN111526876A (zh) * | 2017-12-28 | 2020-08-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
Non-Patent Citations (3)
| Title |
|---|
| KOÇLUK Y,等: "Efficacy of Monotherapy with Either Bimatoprost or Travoprost in Patients with Primary Open-Angle Glaucoma Resistant to Latanoprost Therapy", TURK J OPHTHALMOL, vol. 41, no. 5, 31 October 2011 (2011-10-31), pages 295 - 298, XP009534908, DOI: 10.4274/tjo.41.36844 * |
| MILLER ELLIS E,等: "Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study", BR J OPHTHALMOL, vol. 101, no. 6, 20 September 2016 (2016-09-20), pages 797 * |
| YAMANE S,等: "IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys", INVEST OPHTHALMOL VIS SCI, vol. 56, no. 4, 30 April 2015 (2015-04-30), pages 2548, XP055765498, DOI: 10.1167/iovs.14-16181 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2022034909A1 (cg-RX-API-DMAC7.html) | 2022-02-17 |
| EP4197540A4 (en) | 2024-06-19 |
| KR20230051199A (ko) | 2023-04-17 |
| TW202220666A (zh) | 2022-06-01 |
| US20230285411A1 (en) | 2023-09-14 |
| WO2022034909A1 (ja) | 2022-02-17 |
| EP4197540A1 (en) | 2023-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6383058B2 (ja) | スルホンアミド化合物の組み合わせ | |
| JP4934653B2 (ja) | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 | |
| JP2023110030A (ja) | セペタプロストとRhoキナーゼ阻害剤との組み合わせ医薬 | |
| TW202220666A (zh) | 含有賽佩普斯特(sepetaprost)之醫藥製劑 | |
| US11666563B2 (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| CN111491636A (zh) | 奥米帕格的组合 | |
| HK40102807A (en) | Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| HK40102807B (en) | Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| HK40029828A (en) | Omidenepag combination | |
| EA043474B1 (ru) | Комбинация омиденепага | |
| HK40025370A (en) | Omidenepag combination | |
| HK40024494A (en) | MEDICAMENT COMPRISING COMBINATION OF SEPETAPROST AND Rho-KINASE INHIBITOR | |
| HK40029829B (en) | Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| HK40031074A (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| EA050493B1 (ru) | ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ КОМБИНАЦИЮ СЕПЕТАПРОСТА И ИНГИБИТОРА Rho-АССОЦИИРОВАННОЙ ПРОТЕИНКИНАЗЫ, СОДЕРЖАЩЕЙ СУПЕРСПИРАЛЬ | |
| JP2000336042A (ja) | 眼圧下降剤 | |
| JP2003531853A (ja) | 眼圧降下剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |